Literature DB >> 2901342

Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens.

N Kyprianou1, J T Isaacs.   

Abstract

Scatchard analyses of the binding of transforming growth factor-beta (TGF beta) to membranes from rat ventral prostate revealed the presence of high affinity (Kd = 140 pM) saturable binding sites for [125I]TGF beta. The binding of [125I]TGF beta to prostatic membranes, while displaced in the presence of excess unlabeled TGF beta, is unaffected by epidermal growth factor, nerve growth factor, fibroblast growth factor, or insulin, indicating the specificity of binding. Affinity labeling of these membrane receptors by covalent attachment to [125I]TGF beta with bis-(sulfosuccinimidyl)suberate and subsequent electrophoretic analysis of the labeled complexes revealed the specific binding of [125I]TGF beta to a macromolecule that predominantly migrates as a 260,000 mol wt band in 7.5% acrylamide gels. Castration-induced androgen deprivation produced a significant increase in [125I]TGF beta binding to prostatic membranes with no apparent change in the affinity of membrane receptors for TGF beta. TGF beta receptor levels per total gland increased approximately 2-fold by 3 days after castration, reached a peak value by day 4, and then declined during the subsequent 10 days. Androgen administration to 4-day castrated animals decreased the number of TGF beta receptors to a value similar to that in the intact controls. These results demonstrate the presence of specific binding sites for TGF beta in the rat ventral prostate. Furthermore, the TGF beta receptor levels seem to be under negative androgenic regulation, indicating a potential role for this growth factor in the mechanism of activation of castration-induced death of androgen-dependent epithelial cells in the ventral prostate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901342     DOI: 10.1210/endo-123-4-2124

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

Review 1.  Prostate gland: structure, functions and regulation.

Authors:  V L Kumar; P K Majumder
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 2.  Fibroblasts are critical determinants in prostatic cancer growth and dissemination.

Authors:  L W Chung
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

3.  The Endocrine Society Centennial: Hormones and Apoptosis in the Prostate Gland… Live and Let Die.

Authors:  Gail S Prins
Journal:  Endocrinology       Date:  2016-06       Impact factor: 4.736

Review 4.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

Review 5.  Growth factors as mediators of androgen action during the development of the male urogenital tract.

Authors:  G R Cunha; B Foster; A Thomson; Y Sugimura; N Tanji; M Tsuji; N Terada; P W Finch; A A Donjacour
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 6.  EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.

Authors:  Rama Soundararajan; Anurag N Paranjape; Sankar Maity; Ana Aparicio; Sendurai A Mani
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-07-05       Impact factor: 10.680

Review 7.  Exploring the origins of the normal prostate and prostate cancer stem cell.

Authors:  Susan Kasper
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

8.  Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Seong-Jin Kim; David Danielpour
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 9.  Regulation of prostate growth by fibroblast growth factors.

Authors:  M T Story
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

10.  LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.

Authors:  K S Hirsch; C D Jones; J E Audia; S Andersson; L McQuaid; N B Stamm; B L Neubauer; P Pennington; R E Toomey; D W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.